These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6409892)

  • 21. Relationship between the Newcastle scale and sleep polysomnographic variables in major depression: a controlled study.
    Hubain PP; Souery D; Jönck L; Staner L; Van Veeren C; Kerkhofs M; Mendlewicz J; Linkowski P
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):129-34. PubMed ID: 7549455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 24. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute hospitalization on the dexamethasone suppression and TRH stimulation tests.
    Roy-Byrne P; Gwirtsman H; Sternbach H; Gerner RH
    Biol Psychiatry; 1984 Apr; 19(4):607-12. PubMed ID: 6428471
    [No Abstract]   [Full Text] [Related]  

  • 26. DST and TRH stimulation test in mood disorder subtypes.
    Levy AB; Stern SL
    Am J Psychiatry; 1987 Apr; 144(4):472-5. PubMed ID: 3105335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of neuroendocrine function tests in the differential diagnosis of depression].
    Cervera S
    Rev Esp Fisiol; 1989; 45 Suppl():279-87. PubMed ID: 2518335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited clinical utility of urinary MHPG.
    Lieber AL
    Hillside J Clin Psychiatry; 1988; 10(1):98-104. PubMed ID: 3137145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R; Brown P; Bienenstock A; Mitton J
    Biol Psychiatry; 1984 Mar; 19(3):347-52. PubMed ID: 6426532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological markers of melancholia and reclassification of depressive disorders.
    Greden JF
    Encephale; 1982; 8(2):193-202. PubMed ID: 6809444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder.
    Reist C; Kauffmann CD; Chicz-Demet A; Chen CC; Demet EM
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):433-43. PubMed ID: 7624494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep EEG and DST findings in anergic bipolar depression.
    Thase ME; Himmelhoch JM; Mallinger AG; Jarrett DB; Kupfer DJ
    Am J Psychiatry; 1989 Mar; 146(3):329-33. PubMed ID: 2919689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis.
    Hubain PP; Staner L; Dramaix M; Kerkhofs M; Papadimitriou G; Mendlewicz J; Linkowski P
    Biol Psychiatry; 1998 Feb; 43(3):220-9. PubMed ID: 9494704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological correlates of the dexamethasone suppression test response and of the shortened REM sleep latency in depressed outpatients.
    Cluydts RJ; De Roeck JM; Beckham BJ
    Acta Psychiatr Belg; 1987; 87(3):317-24. PubMed ID: 3673632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.